| In millions, except per share items | Jun-30-22 | Jun-30-21 | Jun-30-20 | Jun-30-19 | Jun-30-18 |
| | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| UNITED KINGDOM | 0.7 | 0.3 | | | |
| Dalrada Energy | 1.3 | | | | |
| Dalrada Health | 13.6 | 1.7 | | | |
| Dalrada Precision Manufacturing | 2.1 | 0.5 | | | |
| Other | 1.5 | 0.9 | | | |
| Total revenues | 19.3 | 3.4 | 1.2 | 0.1 | 0.0 |
| Revenue growth [+] | 465.6% | 189.2% | 1532.8% | | |
| UNITED KINGDOM | 125.8% | | | | |
| Dalrada Health | 682.9% | | | | |
| Dalrada Precision Manufacturing | 341.2% | | | | |
| Dalrada Technologies | 88.9% | | | | |
| Cost of goods sold | 8.8 | 2.5 | 0.6 | 0.1 | 0.0 |
| Gross profit | 10.5 | 0.9 | 0.6 | 0.0 | 0.0 |
| Gross margin | 54.5% | 27.4% | 46.9% | -3.9% | |
| Selling, general and administrative | 20.9 | 9.5 | 2.8 | 0.7 | 0.1 |
| Research and development | | | 0.5 | 0.1 | |
| Other operating expenses | 2.0 | -17.1 | | 0.3 | -1.9 |
| EBITDA [+] | -12.1 | 8.7 | -2.6 | | |
| EBITDA growth | -239.1% | -429.8% | 152.8% | -158.1% | |
| EBITDA margin | -62.9% | 255.8% | -224.3% | -1448.7% | |
| Depreciation and amortization | 0.3 | 0.1 | 0.0 | | |
| EBIT [+] | -12.4 | 8.6 | -2.7 | -1.0 | 1.8 |
| EBIT growth | -245.2% | -418.8% | 157.3% | -158.1% | |
| EBIT margin | -64.6% | 251.6% | -228.2% | -1448.7% | |
| Interest expense, net [+] | | | 1.0 | 0.9 | 0.9 |
| Interest expense | 1.3 | 0.7 | 1.0 | 0.9 | 0.9 |
| Interest income | | | 0.0 | | |
| Other income (expense), net [+] | 2.3 | -7.9 | 1.2 | 2.3 | -0.9 |
| Gain (loss) on foreign currency transactions | | | 0.0 | | |
| Pre-tax income | -11.4 | 0.0 | -2.5 | 0.4 | -0.1 |
| Income taxes | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | | 0.0% | 0.0% | 0.0% | 0.0% |
| Minority interest | | | 0.0 | | |
| Net income | -14.1 | 0.1 | -2.5 | 0.4 | -1.0 |
| Net margin | -73.2% | 2.7% | -209.3% | 507.0% | |
| |
| Basic EPS [+] | ($0.20) | $0.00 | ($0.04) | $0.01 | ($0.02) |
| Growth | -15113.7% | -103.0% | -662.9% | -135.2% | |
| Diluted EPS [+] | ($0.20) | $0.00 | ($0.04) | $0.00 | ($0.02) |
| Growth | -27631.4% | -101.6% | -1317.4% | -116.3% | |
| |
| Shares outstanding (basic) [+] | 72.2 | 70.3 | 56.8 | 47.4 | 47.3 |
| Growth | 2.7% | 23.8% | 19.8% | 0.3% | |
| Shares outstanding (diluted) [+] | 72.2 | 128.9 | 56.8 | 102.6 | 47.3 |
| Growth | -44.0% | 127.0% | -44.6% | 116.9% | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |